Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the benefit of ACTH (Acthar) in reducing proteinuria
associated with transplant glomerulopathy in non-diabetic kidney transplant recipients.